Heterozygote advantage for HLA class-II type in hepatitis B virus infection
Mark Thursz(St Mary's Hospital), Adrian V. S. Hill(University of Oxford), Brian Greenwood(MRC Unit the Gambia), Howard C. Thomas(St Mary's Hospital)
Cited by 319
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION
|The Lancet|1989|1.2k
Vaccine-induced escape mutant of hepatitis B virus
|The Lancet|1990|1.1k
Cholangiocarcinoma
|The Lancet|2005|1.1k
Viral dynamics in hepatitis B virus infection.
|Proceedings of the National Academy of Sciences|1996|1k